SIGMAR1 and neurodegenerative disease: Broadly, Sigmar1 activation using ligands elicit potent neuroprotective effects, promotes neuronal survival, and restores neuronal plasticity to slow disease progression, whereas dysfunction in Sigmar1 may worsen the progression of neurodegenerative diseases.